» Authors » Shabnam Shahrokh

Shabnam Shahrokh

Explore the profile of Shabnam Shahrokh including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 96
Citations 766
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Khosravany Z, Khodavaisy S, Olyaiee A, Sadeghi A, Nemati S, Shahrokh S, et al.
Front Med (Lausanne) . 2025 Feb; 12:1514587. PMID: 40018349
Objective: Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are gastrointestinal disorders, which can be triggered by gut microbiota dysbiosis. The development of IBS-like symptoms has been linked to...
2.
Safaei F, Shahrokh S, Naderi N, Rastegar R, Shamsi A
Front Med (Lausanne) . 2024 Dec; 11:1468885. PMID: 39635600
Introduction: This clinical trial is designed to explore the efficacy of paroxetine and gabapentin in alleviating functional gastrointestinal symptoms, anxiety, depression, and quality of life in patients with ulcerative colitis...
3.
Narimani B, Sadeghi A, Ebrahimi Daryani N, Shahrokh S, Nilghaz M, Ghods M, et al.
Sci Rep . 2024 Jun; 14(1):13791. PMID: 38877032
Dietary intake plays a pivotal role in ulcerative colitis (UC) initiation and prognosis. The aim of this study was to investigate the effect of a combined Mediterranean, low-FODMAP diet accompanied...
4.
Kazemifard N, Farmani M, Ghavami S, Kazemi M, Shahrokh S, Aghdaei H, et al.
Biochem Biophys Rep . 2024 May; 38:101731. PMID: 38766384
Long non-coding RNAs (lncRNAs) regulate multiple pathways and cellular mechanisms. Recent research has emphasized their involvement in the pathogenesis of complex diseases, such as Inflammatory Bowel Disease (IBD) which is...
5.
Pourhoseingholi M, Yazdani O, Azizmohammad Looha M, Safavi-Naini S, Esbati R, Ilkhani S, et al.
Curr Med Chem . 2024 Jan; PMID: 38251698
Background: This study investigated the association of atorvastatin use on survival, need for intensive care unit (ICU) admission, and length of hospital stay (LOS) among COVID-19 inpatients. Materials And Methods:...
6.
Nemati Bajestan M, Piroozkhah M, Chaleshi V, Ghiasi N, Jamshidi N, Mirfakhraie R, et al.
Iran J Allergy Asthma Immunol . 2023 Dec; 22(5):482-494. PMID: 38085149
 Inflammatory bowel disease (IBD) manifests as chronic inflammation within the gastrointestinal tract. The study focuses on a long noncoding RNA (lncRNA) known as Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1). MALAT1's...
7.
Nazari M, Shahrokh S, Ghanbari-Maman L, Maleknia S, Ghorbaninejad M, Meyfour A
Heliyon . 2023 Nov; 9(11):e21154. PMID: 37928018
Nowadays, anti-TNF therapy remarkably improves the medical management of ulcerative colitis (UC), but approximately 40 % of patients do not respond to this treatment. In this study, we used 79...
8.
Heydari R, Fayazzadeh S, Shahrokh S, Shekari F, Farsad F, Meyfour A
Inflamm Bowel Dis . 2023 Oct; 30(5):795-807. PMID: 37855715
Background: Inflammatory bowel disease (IBD) is a complex gastrointestinal disease with 2 main subtypes of Crohn's disease (CD) and ulcerative colitis (UC), whose diagnosis mainly depends on the medical history,...
9.
Khanabadi B, Najafgholizadeh Seyfi D, Rejali L, Taleghani M, Tavallaei M, Shahrokh S, et al.
Gastroenterol Hepatol Bed Bench . 2023 Sep; 16(3):341-346. PMID: 37767326
Based on the analysis of patients with Peutz-Jeghers syndrome (PJS), Serine threonine kinase11 (STK11) is known as a tumor suppressor gene, which is involved in cell polarization, regulation of apoptosis,...
10.
Rahni Z, Hosseini S, Shahrokh S, Saeedi Niasar M, Shoraka S, Mirjalali H, et al.
Virus Res . 2023 Sep; 336:199214. PMID: 37657511
The current outbreak of coronavirus disease 2019 (COVID-19) is a global emergency, as its rapid spread and high mortality rate, which poses a significant threat to public health. Innate immunity...